Pregabalin Exerts Oppositional Effects on Different Inhibitory Circuits in Human Motor Cortex: A Double‐blind, Placebo‐controlled Transcranial Magnetic Stimulation Study
Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS). Methods: PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double‐blind, placebo‐controlled crossover design. Several mea...
Saved in:
| Published in | Epilepsia (Copenhagen) Vol. 47; no. 5; pp. 813 - 819 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Malden, USA
Blackwell Publishing Inc
01.05.2006
Blackwell |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0013-9580 1528-1157 1528-1167 1528-1167 |
| DOI | 10.1111/j.1528-1167.2006.00544.x |
Cover
| Abstract | Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).
Methods: PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double‐blind, placebo‐controlled crossover design. Several measures of motor cortex excitability were tested with single‐ and paired‐pulse TMS.
Results: Mean short‐interval intracortical inhibition (SICI) was reduced after PGB (74 ± 7% of unconditioned response) compared with placebo (60 ± 6% of unconditioned response). In contrast, mean long‐interval intracortical inhibition (LICI) was increased by PGB (26 ± 4% of unconditioned response) compared with placebo (45 ± 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 ± 8 ms or 145 ± 8 ms after placebo to 162 ± 7 ms or 161 ± 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected.
Conclusions: The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest γ‐aminobutyric acid (GABA)B‐receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the α(2)‐δ subunit of voltage‐gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA‐reuptake inhibitor tiagabine. |
|---|---|
| AbstractList | To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).PURPOSETo explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double-blind, placebo-controlled crossover design. Several measures of motor cortex excitability were tested with single- and paired-pulse TMS.METHODSPGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double-blind, placebo-controlled crossover design. Several measures of motor cortex excitability were tested with single- and paired-pulse TMS.Mean short-interval intracortical inhibition (SICI) was reduced after PGB (74 +/- 7% of unconditioned response) compared with placebo (60 +/- 6% of unconditioned response). In contrast, mean long-interval intracortical inhibition (LICI) was increased by PGB (26 +/- 4% of unconditioned response) compared with placebo (45 +/- 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 +/- 8 ms or 145 +/- 8 ms after placebo to 162 +/- 7 ms or 161 +/- 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected.RESULTSMean short-interval intracortical inhibition (SICI) was reduced after PGB (74 +/- 7% of unconditioned response) compared with placebo (60 +/- 6% of unconditioned response). In contrast, mean long-interval intracortical inhibition (LICI) was increased by PGB (26 +/- 4% of unconditioned response) compared with placebo (45 +/- 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 +/- 8 ms or 145 +/- 8 ms after placebo to 162 +/- 7 ms or 161 +/- 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected.The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest gamma-aminobutyric acid (GABA)B-receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the alpha2-delta subunit of voltage-gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA-reuptake inhibitor tiagabine.CONCLUSIONSThe observed excitability changes with oppositional effects on SICI and LICI or CSP suggest gamma-aminobutyric acid (GABA)B-receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the alpha2-delta subunit of voltage-gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA-reuptake inhibitor tiagabine. Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS). Methods: PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double‐blind, placebo‐controlled crossover design. Several measures of motor cortex excitability were tested with single‐ and paired‐pulse TMS. Results: Mean short‐interval intracortical inhibition (SICI) was reduced after PGB (74 ± 7% of unconditioned response) compared with placebo (60 ± 6% of unconditioned response). In contrast, mean long‐interval intracortical inhibition (LICI) was increased by PGB (26 ± 4% of unconditioned response) compared with placebo (45 ± 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 ± 8 ms or 145 ± 8 ms after placebo to 162 ± 7 ms or 161 ± 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected. Conclusions: The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest γ‐aminobutyric acid (GABA)B‐receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the α(2)‐δ subunit of voltage‐gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA‐reuptake inhibitor tiagabine. Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS). Methods: PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double‐blind, placebo‐controlled crossover design. Several measures of motor cortex excitability were tested with single‐ and paired‐pulse TMS. Results: Mean short‐interval intracortical inhibition (SICI) was reduced after PGB (74 ± 7% of unconditioned response) compared with placebo (60 ± 6% of unconditioned response). In contrast, mean long‐interval intracortical inhibition (LICI) was increased by PGB (26 ± 4% of unconditioned response) compared with placebo (45 ± 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 ± 8 ms or 145 ± 8 ms after placebo to 162 ± 7 ms or 161 ± 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected. Conclusions: The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest γ‐aminobutyric acid (GABA) B ‐receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the α(2)‐δ subunit of voltage‐gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA‐reuptake inhibitor tiagabine. To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS). PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double-blind, placebo-controlled crossover design. Several measures of motor cortex excitability were tested with single- and paired-pulse TMS. Mean short-interval intracortical inhibition (SICI) was reduced after PGB (74 +/- 7% of unconditioned response) compared with placebo (60 +/- 6% of unconditioned response). In contrast, mean long-interval intracortical inhibition (LICI) was increased by PGB (26 +/- 4% of unconditioned response) compared with placebo (45 +/- 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 +/- 8 ms or 145 +/- 8 ms after placebo to 162 +/- 7 ms or 161 +/- 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected. The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest gamma-aminobutyric acid (GABA)B-receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the alpha2-delta subunit of voltage-gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA-reuptake inhibitor tiagabine. |
| Author | Paulus, Walter Tergau, Frithjof Lang, Nicolas Hasan, Alkomiet Sueske, Elke |
| Author_xml | – sequence: 1 givenname: Nicolas surname: Lang fullname: Lang, Nicolas – sequence: 2 givenname: Elke surname: Sueske fullname: Sueske, Elke – sequence: 3 givenname: Alkomiet surname: Hasan fullname: Hasan, Alkomiet – sequence: 4 givenname: Walter surname: Paulus fullname: Paulus, Walter – sequence: 5 givenname: Frithjof surname: Tergau fullname: Tergau, Frithjof |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17835066$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16686645$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVUUFu1DAUtVARnRaugLyBFQl2EtsJQkjVdKAjtepIlLXlOE7xyGOntqPO7DgCF-FSnASnM6ISq-KF_fX93n9f752AI-usAgBilON03q9zTIo6w5iyvECI5giRqsq3z8Ds78cRmCGEy6whNToGJyGsEUKMsvIFOMaU1pRWZAZ-rby6Fa0w2sLFVvkY4PUwuKCjdlYYuOh7JVPTWXiuU-2VjXBpv-tWR-d3cK69HHUCJP7FuBEWXrn0AefOR7X9AM_guRtbo37_-Nkmje4dXBkhVetSQzobvTNGdfDGCxtkunTSvBK3VkUt4deoN6MR0yqpHrvdS_C8FyaoV4f3FHz7vLiZX2SX11-W87PLTFYMV1nBJC1KSohEVVGQqkGklAVpUd0VGEtW9C1WDatKSWuJREN6ihjBSvYMdUWLy1PQ7OeOdhC7e2EMH7zeCL_jGPEpAr7mk9N8cppPEfCHCPg2cd_uuYN3d6MKkW90kMoYYZUbA6esIayqJpHXB-DYblT3qHAIJwHeHAAiSGH6ZI_U4RHH6pIgShOu3uOkdyF41f_Psp_-oUodHwyPXmjzlAEf9wPutVG7JwvzxWqZivIPbsDaUA |
| CODEN | EPILAK |
| CitedBy_id | crossref_primary_10_1016_j_neubiorev_2017_10_006 crossref_primary_10_1097_WNP_0000000000000784 crossref_primary_10_3389_fpsyt_2021_676224 crossref_primary_10_4085_1062_6050_46_3_234 crossref_primary_10_1016_j_eplepsyres_2013_09_006 crossref_primary_10_1016_j_jsps_2020_11_001 crossref_primary_10_1111_j_1369_1600_2007_00093_x crossref_primary_10_1016_j_smrv_2024_102027 crossref_primary_10_1016_j_encep_2020_02_008 crossref_primary_10_1016_j_brs_2008_06_002 crossref_primary_10_1080_00952990_2025_2467458 crossref_primary_10_1093_cercor_bhr003 crossref_primary_10_1016_j_eplepsyres_2016_06_004 crossref_primary_10_1097_j_pain_0000000000000324 crossref_primary_10_1517_17425255_2013_749239 crossref_primary_10_1016_j_clinph_2011_11_034 crossref_primary_10_1016_j_parkreldis_2024_107151 crossref_primary_10_1016_j_clinph_2014_08_028 crossref_primary_10_1016_j_jsps_2023_101935 crossref_primary_10_3390_brainsci11060705 crossref_primary_10_1007_s00421_014_2884_z crossref_primary_10_1016_j_neurol_2010_10_013 crossref_primary_10_1038_s41598_019_51556_4 crossref_primary_10_1186_1471_2377_13_43 crossref_primary_10_1007_s40263_015_0303_6 crossref_primary_10_1016_j_brs_2016_04_019 crossref_primary_10_3389_fnhum_2018_00406 crossref_primary_10_1016_j_seizure_2013_05_010 crossref_primary_10_1016_j_medidd_2021_100083 crossref_primary_10_1016_j_clinph_2006_05_030 crossref_primary_10_1586_14737175_8_7_1013 crossref_primary_10_1016_j_neuroscience_2015_05_057 crossref_primary_10_1016_j_brs_2016_11_009 crossref_primary_10_1016_j_sleep_2015_03_018 |
| Cites_doi | 10.1111/j.1600-0404.1996.tb00047.x 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.0.CO;2-M 10.1016/0028-3932(71)90067-4 10.1176/appi.ajp.160.3.533 10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B 10.1016/S0028-3908(01)00140-X 10.1212/01.WNL.0000068024.20285.65 10.1046/j.1528-1157.2001.01600.x 10.1016/S0028-3908(01)00181-2 10.1016/S1059-1311(02)00295-9 10.1124/mol.59.1.144 10.1111/j.0013-9580.2004.31203.x 10.1016/j.eplepsyres.2003.08.006 10.1016/S0304-3959(03)00173-8 10.1016/S0304-3959(01)00316-5 10.1016/j.clinph.2004.03.006 10.1016/0168-5597(92)90048-G 10.1016/S0304-3940(00)00769-2 10.1111/j.1469-7793.2001.0307l.x 10.1007/s100720100002 10.1212/01.WNL.0000038744.30298.D4 10.1016/S0924-980X(98)00038-1 10.1212/01.WNL.0000145767.36287.A1 10.1016/S0022-3565(24)29346-0 10.1016/S0028-3908(01)00172-1 10.1038/sj.bjp.0704439 10.1093/brain/awh398 10.1124/mol.61.6.1377 10.1111/j.1469-7793.1999.0591t.x 10.1002/ana.10473 10.1053/seiz.2001.0594 10.1002/ana.410400306 10.1152/jn.1992.67.6.1698 10.1113/jphysiol.1993.sp019912 10.1016/S0074-7742(08)60304-9 10.1212/WNL.49.3.881 10.1002/ana.410370204 10.1212/01.WNL.0000055433.55136.55 10.1016/j.clinph.2004.12.004 10.1212/01.WNL.0000150932.48688.BE 10.1152/jn.1992.67.1.227 10.1007/BF00228633 10.1111/j.1469-7793.1998.181bi.x |
| ContentType | Journal Article |
| Copyright | 2006 INIST-CNRS |
| Copyright_xml | – notice: 2006 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
| DOI | 10.1111/j.1528-1167.2006.00544.x |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1528-1167 |
| EndPage | 819 |
| ExternalDocumentID | 10.1111/j.1528-1167.2006.00544.x 16686645 17835066 10_1111_j_1528_1167_2006_00544_x EPI544 |
| Genre | article Randomized Controlled Trial Journal Article Comparative Study |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29G 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAGKA AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIVO ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FYBCS G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OHT OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V8K V9Y VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAFWJ AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c4714-27c623655c0422549053c25b08d211c72fb1e9743c68c0a95f60751ecf70d2b13 |
| IEDL.DBID | UNPAY |
| ISSN | 0013-9580 1528-1157 1528-1167 |
| IngestDate | Wed Oct 01 16:11:07 EDT 2025 Thu Oct 02 06:16:43 EDT 2025 Wed Feb 19 01:54:35 EST 2025 Mon Jul 21 09:11:52 EDT 2025 Thu Apr 24 23:01:11 EDT 2025 Wed Oct 01 04:32:27 EDT 2025 Wed Jan 22 16:27:08 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Human Nervous system diseases Transcranial magnetic stimulation Motor pathway Calcium Epilepsy Central nervous system Anticonvulsant Pregabalin Inorganic element Cerebral disorder Analgesic Motor cortex Central nervous system disease Voltage Neurotransmitter GABA Pregabalin-Transcranial magnetic stimulation-Intracortical inhibition-Silent period-GABA- Voltage-dependent calcium channel |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4714-27c623655c0422549053c25b08d211c72fb1e9743c68c0a95f60751ecf70d2b13 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1528-1167.2006.00544.x |
| PMID | 16686645 |
| PQID | 67957441 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | unpaywall_primary_10_1111_j_1528_1167_2006_00544_x proquest_miscellaneous_67957441 pubmed_primary_16686645 pascalfrancis_primary_17835066 crossref_primary_10_1111_j_1528_1167_2006_00544_x crossref_citationtrail_10_1111_j_1528_1167_2006_00544_x wiley_primary_10_1111_j_1528_1167_2006_00544_x_EPI544 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | May 2006 |
| PublicationDateYYYYMMDD | 2006-05-01 |
| PublicationDate_xml | – month: 05 year: 2006 text: May 2006 |
| PublicationDecade | 2000 |
| PublicationPlace | Malden, USA |
| PublicationPlace_xml | – name: Malden, USA – name: Malden, MA – name: United States |
| PublicationTitle | Epilepsia (Copenhagen) |
| PublicationTitleAlternate | Epilepsia |
| PublicationYear | 2006 |
| Publisher | Blackwell Publishing Inc Blackwell |
| Publisher_xml | – name: Blackwell Publishing Inc – name: Blackwell |
| References | 2004; 63 2001; 93 2002; 59 1996; 109 1995; 37 2002; 135 2004; 45 2005; 116 2002; 11 1996; 94 2005; 64 2000; 295 1997; 49 1998; 511 2001; 22 1998; 21 2003; 53 2001; 41 2001; 42 2003; 12 2003; 56 2001; 298 1971; 9 2001; 530 2004; 115 2003; 105 2002; 42 2002; 61 1999; 19 2005; 128 2003; 160 1993; 471 1994; 36 1997; 38 1996; 40 1998; 109 2001; 59 1999; 52 2003; 60 1992; 67 1999; 517 2000; 280 1992; 85 e_1_2_6_31_2 e_1_2_6_30_2 e_1_2_6_18_2 e_1_2_6_19_2 e_1_2_6_13_2 e_1_2_6_34_2 Welty D (e_1_2_6_12_2) 1997; 38 e_1_2_6_33_2 e_1_2_6_11_2 e_1_2_6_32_2 e_1_2_6_16_2 e_1_2_6_39_2 e_1_2_6_17_2 e_1_2_6_38_2 e_1_2_6_14_2 e_1_2_6_37_2 e_1_2_6_15_2 e_1_2_6_36_2 Bertrand S (e_1_2_6_35_2) 2001; 298 e_1_2_6_42_2 Dooley DJ (e_1_2_6_10_2) 2000; 295 e_1_2_6_41_2 e_1_2_6_40_2 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_3_2 e_1_2_6_6_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_47_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_22_2 e_1_2_6_21_2 Rothwell JC (e_1_2_6_20_2) 1999; 52 e_1_2_6_28_2 e_1_2_6_43_2 e_1_2_6_27_2 e_1_2_6_44_2 e_1_2_6_26_2 e_1_2_6_45_2 e_1_2_6_25_2 e_1_2_6_46_2 |
| References_xml | – volume: 295 start-page: 1086 year: 2000 end-page: 1093 article-title: Stimulus‐dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin publication-title: J Pharmacol Exp Ther – volume: 38 start-page: 35 issue: suppl 8 year: 1997 end-page: 36 article-title: Pharmacokinetics (PK) and pharmacodynamics (PD) of CI‐1008 (pregabalin) and gabapentin in rats with maximal electroshock publication-title: Epilepsia – volume: 109 start-page: 127 year: 1996 end-page: 135 article-title: The effect of lorazepam on the motor cortical excitability in man publication-title: Exp Brain Res – volume: 40 start-page: 367 year: 1996 end-page: 378 article-title: Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study publication-title: Ann Neurol – volume: 85 start-page: 355 year: 1992 end-page: 364 article-title: Human motor evoked responses to paired transcranial magnetic stimuli publication-title: Electroencephalogr Clin Neurophysiol – volume: 42 start-page: 353 year: 2002 end-page: 366 article-title: Gabapentin‐mediated inhibition of voltage‐activated Ca2 channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression publication-title: Neuropharmacology – volume: 19 start-page: 149 year: 1999 end-page: 177 article-title: 3‐Substituted GABA analogs with central nervous system activity: a review publication-title: Med Res Rev – volume: 22 start-page: 229 year: 2001 end-page: 232 article-title: Modification of cortical excitability induced by gabapentin: a study by transcranial magnetic stimulation publication-title: Neurol Sci – volume: 109 start-page: 397 year: 1998 end-page: 401 article-title: Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans publication-title: Electroencephalogr Clin Neurophysiol – volume: 45 start-page: 20 year: 2004 end-page: 27 article-title: Pregabalin add‐on treatment: a randomized, double‐blind, placebo‐controlled, dose‐response study in adults with partial seizures publication-title: Epilepsia – volume: 41 start-page: 965 year: 2001 end-page: 975 article-title: Gabapentin is not a GABA receptor agonist publication-title: Neuropharmacology – volume: 116 start-page: 1105 year: 2005 end-page: 1112 article-title: Cortical excitability during prolonged antiepileptic drug treatment and drug withdrawal publication-title: Clin Neurophysiol – volume: 94 start-page: 367 year: 1996 end-page: 377 article-title: Seizure‐inducing effects of antiepileptic drugs: a review publication-title: Acta Neurol Scand – volume: 93 start-page: 191 year: 2001 end-page: 196 article-title: Gabapentin inhibits the substance P‐facilitated K(+)‐evoked release of ((3)H)glutamate from rat caudal trigeminal nucleus slices publication-title: Pain – volume: 59 start-page: 1851 year: 2002 end-page: 1859 article-title: Transcranial magnetic stimulation techniques in clinical investigation publication-title: Neurology – volume: 280 start-page: 107 year: 2000 end-page: 110 article-title: Inhibition of K( )‐evoked glutamate release from rat neocortical and hippocampal slices by gabapentin publication-title: Neurosci Lett – volume: 67 start-page: 1698 year: 1992 end-page: 1701 article-title: Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures publication-title: J Neurophysiol – volume: 11 start-page: 243 year: 2002 end-page: 249 article-title: Tiagabine‐related non‐convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature publication-title: Seizure – volume: 59 start-page: 144 year: 2001 end-page: 152 article-title: Gamma‐aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action publication-title: Mol Pharmacol – volume: 517 start-page: 591 year: 1999 end-page: 597 article-title: Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans publication-title: J Physiol – volume: 9 start-page: 97 year: 1971 end-page: 113 article-title: The assessment and analysis of handedness: the Edinburgh inventory publication-title: Neuropsychologia – volume: 42 start-page: 372 year: 2001 end-page: 379 article-title: Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons publication-title: Epilepsia – volume: 63 start-page: 2104 year: 2004 end-page: 2110 article-title: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial publication-title: Neurology – volume: 471 start-page: 501 year: 1993 end-page: 519 article-title: Corticocortical inhibition in human motor cortex publication-title: J Physiol (Lond) – volume: 64 start-page: 475 year: 2005 end-page: 480 article-title: Safety and efficacy of two pregabalin regimens for add‐on treatment of partial epilepsy publication-title: Neurology – volume: 56 start-page: 67 year: 2003 end-page: 77 article-title: Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation publication-title: Epilepsy Res – volume: 36 start-page: 97 year: 1994 end-page: 223 article-title: The pharmacology and function of central GABA receptors publication-title: Int Rev Neurobiol – volume: 61 start-page: 1377 year: 2002 end-page: 1384 article-title: The anticonvulsant gabapentin (Neurontin) does not act through gamma‐aminobutyric acid‐B receptors publication-title: Mol Pharmacol – volume: 511 start-page: 181 year: 1998 end-page: 190 article-title: Demonstration of facilitatory I wave interaction in the human motor cortex by paired transcranial magnetic stimulation publication-title: J Physiol – volume: 530 start-page: 307 year: 2001 end-page: 317 article-title: Interactions between two different inhibitory systems in the human motor cortex publication-title: J Physiol – volume: 21 start-page: 1209 year: 1998 end-page: 1212 article-title: Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia publication-title: Muscle Nerve – volume: 60 start-page: 1274 year: 2003 end-page: 1283 article-title: Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo‐controlled trial publication-title: Neurology – volume: 128 start-page: 811 year: 2005 end-page: 818. article-title: Motor cortex excitability in focal epilepsies not including the primary motor area: a TMS study publication-title: Brain – volume: 67 start-page: 227 year: 1992 end-page: 235 article-title: Differential activation of GABA and GABA receptors by spontaneously released transmitter publication-title: J Neurophysiol – volume: 12 start-page: 300 year: 2003 end-page: 306 article-title: Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations publication-title: Seizure – volume: 115 start-page: 1717 year: 2004 end-page: 1729 article-title: TMS and drugs publication-title: Clin Neurophysiol – volume: 135 start-page: 257 year: 2002 end-page: 265 article-title: Gabapentin inhibits high‐threshold calcium channel currents in cultured rat dorsal root ganglion neurones publication-title: Br J Pharmacol – volume: 37 start-page: 146 year: 1995 end-page: 157 article-title: Basic mechanisms of generalized absence seizures publication-title: Ann Neurol – volume: 42 start-page: 229 year: 2002 end-page: 236 article-title: Inhibition of neuronal Ca(2 ) influx by gabapentin and pregabalin in the human neocortex publication-title: Neuropharmacology – volume: 53 start-page: 469 year: 2003 end-page: 479 article-title: A novel mechanism underlying drug resistance in chronic epilepsy publication-title: Ann Neurol – volume: 49 start-page: 881 year: 1997 end-page: 883 article-title: Effects of phenytoin on cortical excitability in humans publication-title: Neurology – volume: 105 start-page: 133 year: 2003 end-page: 141 article-title: Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C publication-title: Pain – volume: 52 start-page: 97 year: 1999 end-page: 103 article-title: Magnetic stimulation: motor evoked potentials: the International Federation of Clinical Neurophysiology publication-title: Electroencephalogr Clin Neurophysiol Suppl – volume: 160 start-page: 533 year: 2003 end-page: 540 article-title: Pregabalin in generalized anxiety disorder: a placebo‐controlled trial publication-title: Am J Psychiatry – volume: 298 start-page: 15 year: 2001 end-page: 24 article-title: The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma‐aminobutyric acid type B receptors negatively coupled to voltage‐dependent calcium channels publication-title: J Pharmacol Exp Ther – volume: 60 start-page: 1631 year: 2003 end-page: 1637 article-title: Dose‐response trial of pregabalin adjunctive therapy in patients with partial seizures publication-title: Neurology – ident: e_1_2_6_47_2 doi: 10.1111/j.1600-0404.1996.tb00047.x – ident: e_1_2_6_30_2 doi: 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.0.CO;2-M – ident: e_1_2_6_18_2 doi: 10.1016/0028-3932(71)90067-4 – ident: e_1_2_6_7_2 doi: 10.1176/appi.ajp.160.3.533 – volume: 38 start-page: 35 issue: 8 year: 1997 ident: e_1_2_6_12_2 article-title: Pharmacokinetics (PK) and pharmacodynamics (PD) of CI‐1008 (pregabalin) and gabapentin in rats with maximal electroshock publication-title: Epilepsia – ident: e_1_2_6_43_2 doi: 10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B – ident: e_1_2_6_37_2 doi: 10.1016/S0028-3908(01)00140-X – ident: e_1_2_6_3_2 doi: 10.1212/01.WNL.0000068024.20285.65 – volume: 52 start-page: 97 year: 1999 ident: e_1_2_6_20_2 article-title: Magnetic stimulation: motor evoked potentials: the International Federation of Clinical Neurophysiology publication-title: Electroencephalogr Clin Neurophysiol Suppl – ident: e_1_2_6_45_2 doi: 10.1046/j.1528-1157.2001.01600.x – volume: 295 start-page: 1086 year: 2000 ident: e_1_2_6_10_2 article-title: Stimulus‐dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin publication-title: J Pharmacol Exp Ther – ident: e_1_2_6_38_2 doi: 10.1016/S0028-3908(01)00181-2 – ident: e_1_2_6_13_2 doi: 10.1016/S1059-1311(02)00295-9 – ident: e_1_2_6_34_2 doi: 10.1124/mol.59.1.144 – ident: e_1_2_6_2_2 doi: 10.1111/j.0013-9580.2004.31203.x – ident: e_1_2_6_24_2 doi: 10.1016/j.eplepsyres.2003.08.006 – ident: e_1_2_6_11_2 doi: 10.1016/S0304-3959(03)00173-8 – ident: e_1_2_6_40_2 doi: 10.1016/S0304-3959(01)00316-5 – ident: e_1_2_6_16_2 doi: 10.1016/j.clinph.2004.03.006 – ident: e_1_2_6_22_2 doi: 10.1016/0168-5597(92)90048-G – ident: e_1_2_6_9_2 doi: 10.1016/S0304-3940(00)00769-2 – ident: e_1_2_6_33_2 doi: 10.1111/j.1469-7793.2001.0307l.x – ident: e_1_2_6_17_2 doi: 10.1007/s100720100002 – ident: e_1_2_6_15_2 doi: 10.1212/01.WNL.0000038744.30298.D4 – ident: e_1_2_6_19_2 doi: 10.1016/S0924-980X(98)00038-1 – ident: e_1_2_6_5_2 doi: 10.1212/01.WNL.0000145767.36287.A1 – volume: 298 start-page: 15 year: 2001 ident: e_1_2_6_35_2 article-title: The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma‐aminobutyric acid type B receptors negatively coupled to voltage‐dependent calcium channels publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)29346-0 – ident: e_1_2_6_8_2 doi: 10.1016/S0028-3908(01)00172-1 – ident: e_1_2_6_39_2 doi: 10.1038/sj.bjp.0704439 – ident: e_1_2_6_25_2 doi: 10.1093/brain/awh398 – ident: e_1_2_6_36_2 doi: 10.1124/mol.61.6.1377 – ident: e_1_2_6_31_2 doi: 10.1111/j.1469-7793.1999.0591t.x – ident: e_1_2_6_26_2 doi: 10.1002/ana.10473 – ident: e_1_2_6_44_2 doi: 10.1053/seiz.2001.0594 – ident: e_1_2_6_14_2 doi: 10.1002/ana.410400306 – ident: e_1_2_6_41_2 doi: 10.1152/jn.1992.67.6.1698 – ident: e_1_2_6_21_2 doi: 10.1113/jphysiol.1993.sp019912 – ident: e_1_2_6_32_2 doi: 10.1016/S0074-7742(08)60304-9 – ident: e_1_2_6_29_2 doi: 10.1212/WNL.49.3.881 – ident: e_1_2_6_46_2 doi: 10.1002/ana.410370204 – ident: e_1_2_6_6_2 doi: 10.1212/01.WNL.0000055433.55136.55 – ident: e_1_2_6_27_2 doi: 10.1016/j.clinph.2004.12.004 – ident: e_1_2_6_4_2 doi: 10.1212/01.WNL.0000150932.48688.BE – ident: e_1_2_6_42_2 doi: 10.1152/jn.1992.67.1.227 – ident: e_1_2_6_28_2 doi: 10.1007/BF00228633 – ident: e_1_2_6_23_2 doi: 10.1111/j.1469-7793.1998.181bi.x |
| SSID | ssj0007673 |
| Score | 2.016605 |
| Snippet | Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).
Methods: PGB, 600... Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS). Methods: PGB, 600... To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS). PGB, 600 mg/day, was orally... To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).PURPOSETo explore acute effects of... |
| SourceID | unpaywall proquest pubmed pascalfrancis crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 813 |
| SubjectTerms | Adult Amines - pharmacology Anticonvulsants - pharmacology Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Calcium Channels - drug effects Calcium Channels - physiology Cyclohexanecarboxylic Acids - pharmacology Double-Blind Method Evoked Potentials, Motor - drug effects Evoked Potentials, Motor - physiology Female GABA gamma-Aminobutyric Acid - analogs & derivatives gamma-Aminobutyric Acid - pharmacology gamma-Aminobutyric Acid - physiology Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Intracortical inhibition Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Motor Cortex - drug effects Motor Cortex - physiology Nervous system Nervous system (semeiology, syndromes) Neural Inhibition - drug effects Neural Inhibition - physiology Neurology Neuropharmacology Neurotransmitter Uptake Inhibitors - pharmacology Nipecotic Acids - pharmacology Pharmacology. Drug treatments Placebos Pregabalin Radiodiagnosis. Nmr imagery. Nmr spectrometry Receptors, GABA-B - drug effects Receptors, GABA-B - physiology Recruitment, Neurophysiological - drug effects Recruitment, Neurophysiological - physiology Silent period Transcranial magnetic stimulation Transcranial Magnetic Stimulation - statistics & numerical data Voltage‐dependent calcium channel |
| SummonAdditionalLinks | – databaseName: Wiley Online Library - Core collection (SURFmarket) dbid: DR2 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHngI8X6Ex-IDR1LFSewk3Falq12kQgWstLfIdpzdaENSNYnocuIn8Ef4U_wSZvJoCdrDgrhUVdtp2njG_j7P5xlCXhrfV4oxbWsA1zYgYggp7aS2TJknUl9FKsKzw_N34uDIf3vMj3v9E56F6epDbDbcMDLa-RoDXKpqHOTcBQbERDDkFLjvTxBPwmVadvVhW0kqEH2ymXl2xENnLOq58ItGK9XNpazgpqVdt4uL4OgNcq0plvL8i8zzMdJtl6r92-Rs-JOdQuVs0tRqor_-Uf_x_9yFO-RWj2jpXueCd8kVU9wjV-d9zv4--bFYmROpAO8XdLY2q7qi75eDVgwMu_rJFS0L-qbv1lLTw-I0UxkKAOg0W-kmgw-AfZtyoPMS3qBTlAmvX9M9CiRA5ebnt-8KrpG8ogtMDagSXuiF-LlJaLsoa3iAgKNzeVLg6U36sc4-9w3MKEoqzx-Qo_3Zp-mB3TeJsDWsq77tBuBlnuBcYzUzYLswq2iXKydMgNvqwE0VM0CaPC1C7ciIpwJQEjM6DZzEVcx7SHaKsjCPCU0Sx5VGGEBsBqY2E3Jsm-EFSNKASDsWCQaHiHVfQR0beeTxb0wKRiPG0cD-nqgYhNGI1xZhG8tlV0XkEja7I5_bGuJmHSBFi7wYnDCGOQETPbIwZVPFIoh4ADjXIo8639zaChEK4XOLuBtn_YtfxFtXvLRBPFscwpMn_2j3lFzvNrxQXvqM7NSrxjwHCFir3Ta4fwF7yUxt priority: 102 providerName: Wiley-Blackwell |
| Title | Pregabalin Exerts Oppositional Effects on Different Inhibitory Circuits in Human Motor Cortex: A Double‐blind, Placebo‐controlled Transcranial Magnetic Stimulation Study |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1528-1167.2006.00544.x https://www.ncbi.nlm.nih.gov/pubmed/16686645 https://www.proquest.com/docview/67957441 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1528-1167.2006.00544.x |
| UnpaywallVersion | publishedVersion |
| Volume | 47 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1528-1167 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0007673 issn: 0013-9580 databaseCode: DIK dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVALS databaseName: IngentaConnect Open Access Journals customDbUrl: eissn: 1528-1167 dateEnd: 20140831 omitProxy: true ssIdentifier: ssj0007673 issn: 0013-9580 databaseCode: FIJ dateStart: 20001201 isFulltext: true titleUrlDefault: http://www.ingentaconnect.com/content/title?j_type=online&j_startat=Aa&j_endat=Af&j_pagesize=200&j_page=1 providerName: Ingenta – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0013-9580 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1528-1167 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007673 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB5VqcRDiPfDPMIeOOLUr13H3KKQqkVKiIBI5WR51-ti1bWtxBYpJ34Cf4Q_xS9h1munDeqhIC6RlXhsxzsz-83OtzMAr6TncW7bwhQIrk1ExGhSwkrMKLFdlng84IHaOzydsYOF9-6IHu3ArNsLo-tDbBbclGU0_loZeBkn2s_vXeDjUAejIJv5XV6Bet4AMeUuo4jNe7C7mM1Hn7s2BgFtWqm1Qk0Z0M0Ftmk-l152a-66VUYrfI2J7n9xGUC9CdfrvIzOvkZZto19m8lr_w4U3d_WnJWTQV3xgfj2R0XI__de7sLtFueSkVbMe7Aj8_twbdpm8h_Az_lSHkcco4CcTNZyWa3I-7JjkKGgrqq8IkVO3rY9XCpymH9JeapoAWScLkWd4gko3yQiyLTAH8hYkYfXb8iIYGjAM_nr-w-O94hfk7lKGPACv2jp-ZmMSTNVC_xAMyTT6DhXezrJxyo9bduaEUW0PHsIi_3Jp_GB2baOMAXOtp7p-Kh7LqNUqBpnGAOjrxEO5dYwxohX-E7CbYmhlCvYUFhRQBOG2MmWIvGt2OG2-wh6eZHLJ0Di2HIiySTiOIkOTw6paqbh-ip0w_DaMsDvlCIUbV111d4jCy_EVzgaoRoN1fVT8QhxNMK1AfZGstS1Ra4g09_Su3NBtYSH-NGAl50ihugpVPonymVRr0LmB9RH9GvAY62f57KMDRnzqAHORmH_4oloo45XFggn80M8ePovN3sGN_QamGKcPodetazlC0SFFe9jPPTB6bcG_xvWYFQR |
| linkProvider | Unpaywall |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtNAEF6hIlEQKv_gAu0eOOLIf7u2uVUhVQJ1iaCVerO863Wx6tpRYouUE4_QF-lL8STM-CfBqIeCuERRkokT78zu9-18O0PIG-U4Qpim1CWAax0QMYSUNBI9SkybJ47whY9nh4NDPj52Ppywk7YdEJ6FaepDrDbcMDLq-RoDHDek-1HOLKBAJne7pAJznAEAytsOB9qCCOnzupaUy9t0s2nrPvOMvqzn2m_qrVX3Z9ECblvS9Lu4DpDeI5tVPosuvkVZ1se69WK1_4Bk3d9sNCpng6oUA_n9jwqQ_-k-PCRbLaile40XPiK3VP6Y3AnatP0TcjWdq9NIAOTP6Wip5uWCfpp1cjEwbEooL2iR0_dtw5aSTvKvqUhRA0CH6VxWKXwA7OusAw0KeIMOUSm8fEf3KPAAkamfPy4FXCN-S6eYHRAFvNBq8TMV03pdlvAAMUeD6DTHA5z0S5metz3MKKoqL56S4_3R0XCst30idAlLq6NbLjiazRmTWNAMCC9MLNJiwvBioLfStRJhKuBNtuSeNCKfJRyAkqlk4hqxJUz7GdnIi1y9IDSODStSXAFoUzC7KY9h5wzbRZ4GXNrQiNt5RCjbIurYyyMLfyNTMBohjga2-ETRIIxGuNSIubKcNYVEbmCz03O6tSHu1wFY1Mhu54UhTAuY64lyVVSLkLs-cwHqauR545xrW849zh2mEWvlrX_xi1jtizc2CEfTCTzZ_ke7XbI5PgoOwoPJ4ceX5G6z_4Vq01dko5xX6jUgwlLs1JH-C0fhUI4 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JbtRAEG2hRAogxBrALEkfOOKRt27buUWzKANMGAGRcrPc7XawMLY1YyuTnPgEfoSf4kuo8jKDUQ4BcbEs2-Wtq7pfdb2uIuSVchwhTFPqEsC1DogYTEoasR7Gps1jR_jCx7XDs2N-dOK8OWWnbTkgXAvT5IdYT7ihZdT9NRq4KqK4b-XMAhfI5G4XVGCOMwBAue0w30N-3-jDJpeUy9tws2nrPvOMPq3nyjv1xqo7RbiE3xY39S6uAqS3yc0qK8KL8zBN-1i3Hqwm90jafWbDUfkyqEoxkJd_ZID8T__hPrnbglp62GjhA3JDZQ_JzqwN2z8iP-YLdRYKgPwZHa_UolzS90VHFwPBJoXykuYZHbUFW0o6zT4nIkEOAB0mC1klcAHI11EHOsvhBB0iU3h1QA8p-AEiVT-_fRfwjOg1nWN0QORwoOXipyqi9bgsYQM2R2fhWYYLOOnHMvna1jCjyKq82CUnk_Gn4ZHe1onQJQytjm65oGg2Z0xiQjNweKFjkRYThheBeytdKxamAr_JltyTRuizmANQMpWMXSOyhGk_JltZnqmnhEaRYYWKKwBtCno35TGsnGG76KeBL21oxO00IpBtEnWs5ZEGvzlT0BoBtgaW-ETSILRGsNKIuZYsmkQi15DZ6yndRhDn6wAsamS_08IAugWM9YSZyqtlwF2fuQB1NfKkUc6NLOce5w7TiLXW1r94I1br4rUFgvF8CjvP_lFun-zMR5Pg3fT47XNyq5n-QrLpC7JVLir1EgBhKfZqQ_8FgYBQEg |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtNAEB5VqQRUqPwWXKDsgSMO_tt13FsUUrVICZEgUjlZ3vW6WJi1ldgi5cQj8CJ9KZ6EWf-kDeqhIC6RlXhsxzsz-83OtzMAr6TncW7bwhQIrk1ExGhSwkrMKLFdlng84IHeOzyZsuO59-6Unm7BtNsL09SHWC-4acuo_bU28CJOGj__5gofhzoYBdnM7_IK1PP6iCm3GUVs3oPt-XQ2_NS1MQho3UqtFarLgK4vsEnzufayG3PX3SJa4mtMmv4X1wHUHbhdqSI6_xZl2Sb2rSevo3uQd3-74ax86Vcl74vvf1SE_H_v5T7stjiXDBvFfABbUj2EW5M2k_8ILmYLeRZxjAIUGa_kolyS90XHIEPBpqrykuSKvG17uJTkRH1OeappAWSULkSV4gkoXyciyCTHH8hIk4dXh2RIMDTgmfz14yfHe8SvyUwnDHiOX7T0_EzGpJ6qBX6gGZJJdKb0nk7yoUy_tm3NiCZanj-G-dH44-jYbFtHmAJnW890fNQ9l1EqdI0zjIHR1wiHcmsQY8QrfCfhtsRQyhVsIKwooAlD7GRLkfhW7HDb3YOeypV8CiSOLSeSTCKOk-jw5IDqZhqur0M3DK8tA_xOKULR1lXX7T2y8Ep8haMR6tHQXT81jxBHI1wZYK8li6a2yA1kDjb07lJQL-EhfjTgZaeIIXoKnf6JlMyrZcj8gPqIfg140ujnpSxjA8Y8aoCzVti_eCJaq-ONBcLx7AQP9v_lZs_gTrMGphmnz6FXLir5AlFhyQ9aU_8N48hTKA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pregabalin+exerts+oppositional+effects+on+different+inhibitory+circuits+in+human+motor+cortex%3A+a+double-blind%2C+placebo-controlled+transcranial+magnetic+stimulation+study&rft.jtitle=Epilepsia+%28Copenhagen%29&rft.au=Lang%2C+Nicolas&rft.au=Sueske%2C+Elke&rft.au=Hasan%2C+Alkomiet&rft.au=Paulus%2C+Walter&rft.date=2006-05-01&rft.issn=0013-9580&rft.volume=47&rft.issue=5&rft.spage=813&rft_id=info:doi/10.1111%2Fj.1528-1167.2006.00544.x&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0013-9580&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0013-9580&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0013-9580&client=summon |